跳至主要内容
临床试验/NCT04869735
NCT04869735Unknown不适用

Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization

Université de Reims Champagne-Ardenne1 个研究点 分布在 1 个国家目标入组 2,125 人开始时间: 2021年6月4日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
2,125
试验地点
1
主要终点
DTPolio vaccine delivery

研究概览

简要总结

The aim of vaccination is to protect the patient against disease by stimulating his immune system. DTPolio is a tetravalent vaccine providing protection against pertussis, diphtheria, tetanus and polio.

In France, the vaccination schedule sets the vaccination recommendations applicable to people according to their age. In this schedule, a booster of DTPolio at the age of 25 is recommended.

The vaccination coverage for patients over 16 years of age is insufficient in France.

详细描述

The aim of the study is to evaluate impact of information about booster vaccination against DTPolio at 25 years on this booster vaccination's realization.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
25 Years 至 25 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • aged 25 years old in 2020
  • without delivery of DTPolio vaccine in 2019 or 2020

排除标准

  • 未提供

结局指标

主要结局

DTPolio vaccine delivery

时间窗: 12 months

DTPolio vaccine delivery by pharmacies within 12 months of sending information about booster vaccination against DTPolio at 25 years

次要结局

未报告次要终点

研究者

发起方
Université de Reims Champagne-Ardenne
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验